Figure 1
Figure 1. Kaplan-Meier plot of time to progression for the 56 patients with accelerated-phase CML who had an HR with nilotinib (40 censored observations).

Kaplan-Meier plot of time to progression for the 56 patients with accelerated-phase CML who had an HR with nilotinib (40 censored observations).

Close Modal
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal